Thiotepa Riemser Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiski līdzekļi - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

TIOTEPA KABI 15 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG Sepanyol - Sepanyol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

tiotepa kabi 15 mg polvo para concentrado para solucion para perfusion efg

fresenius kabi espaÑa, s.a.u. - tiotepa - polvo para concentrado para soluciÓn para perfusiÓn - 15 mg - tiotepa 15 mg - tiotepa